Patent · US Active

Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy

US11850238B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

POXEL · FR

Inventors

Sébastien Bolze · Rillieux-la-Pape, FR
Pascale Fouqueray · Val-de-Reuil, FR
Sophie Hallakou-Bozec · Montrouge, FR

Key dates

Filing date	Mar 26, 2021
Grant date	Dec 26, 2023
Priority date	—
Expiry date	Mar 26, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in the treatment of genetic neurodegenerative diseases selected from adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.